Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 499 of 6351
-
New hope for fertility: drug may reverse early menopause in autoimmune patients
Disease control Recruiting nowSeveral autoimmune diseases such as Addison's disease are associated with failing ovarian function, known as premature ovarian insufficiency (POI), which can lead to early menopause and reduced fertility.The underlying cause of POI in these women is considered to be an immunologi…
Phase 3 • Sponsor: Angelica Lindén Hirschberg • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New HIV pill combo shows promise in early trial
Disease control Recruiting nowThis clinical study is testing a new medication, VH4524184, to see if it can effectively treat HIV-1 in adults who have never received treatment for their infection. The study is comparing two different doses of VH4524184, each taken with the medications emtricitabine and tenofov…
Phase 2 • Sponsor: ViiV Healthcare • Aim: Disease control
Last updated Jul 25, 2026 00:00 UTC
-
Could a weekly shot free short bowel patients from IV bags?
Disease control Recruiting nowThe purpose of the present Phase 3 trial is to confirm the efficacy and safety of glepaglutide 10 mg twice weekly in a patient population with SBS-IF and generate additional long-term safety data. Glepaglutide is the International Nonproprietary Name and United States Adopted Na…
Phase 3 • Sponsor: Zealand Pharma • Aim: Disease control
Last updated Aug 14, 2026 00:00 UTC
-
New hope for PNH patients with stubborn anemia
Disease control Recruiting nowThis study is researching an experimental drug called ALN-CFB. The study is focused on people with Paroxysmal Nocturnal Hemoglobinuria (PNH) who are currently taking a complement component C5 inhibitor ("C5-inhibitor") and continue to have anemia (low red blood cell count). The …
Phase 1/2 • Sponsor: Regeneron Pharmaceuticals • Aim: Disease control
Last updated Jul 11, 2026 00:00 UTC
-
New shot could reduce COPD Flare-Ups
Disease control Recruiting nowThe purpose of this clinical trial is to learn about the effects and safety of the study medicine PF-07275315 for the potential treatment of COPD. COPD is a condition that makes it difficult to breathe, which negatively impacts the quality of life and functioning of people who ar…
Phase 2/3 • Sponsor: Pfizer • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New combo attack on lung cancer: drug plus local therapy may delay progression
Disease control Recruiting nowThis is an open-label, multicentre, randomized phase II clinical trial. Patients with stage IV (AJCC 9th edition) non-small cell lung cancer (NSCLC) harboring EGFR exon 19 deletion or exon 21 L858R mutation, who had less than or equal to 3 active oligoresidual cancer sites amenab…
Phase 2 • Sponsor: Chinese University of Hong Kong • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Drawing your way back: could art therapy restore hand movement after stroke?
Disease control Recruiting nowStroke is a leading cause of long-term disability worldwide and frequently results in persistent upper limb impairment, particularly affecting hand dexterity and motor function. These impairments significantly restrict the performance of activities of daily living, reduce functio…
Sponsor: Foundation University Islamabad • Aim: Disease control
Last updated Sep 05, 2026 00:00 UTC
-
New combo aims to boost remission in rare lymphoma
Disease control Recruiting nowThe purpose of this study is to see if the combination of rituximab and venetoclax is effective in treating participants with untreated Marginal Zone Lymphoma (MZL). The names of the study drugs involved in this study are: * Venetoclax (a type of inhibitor) * Rituximab (a type …
Phase 2 • Sponsor: Gottfried von Keudell, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 11:01 UTC
-
Poop pills could help CAR t therapy work better for lymphoma patients
Disease control Recruiting nowThis phase II trial tests how well fecal microbiome transplantation works to remodel intestinal microbiota for patients with lymphoma that has come back after a period of improvement (relapsed) or that does not respond to treatment (refractory) with exposure to high-risk antibiot…
Phase 2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:11 UTC
-
Immune-Boosting drug may help women with repeated IVF failure
Disease control Recruiting nowClinical trial evaluating the safety and efficacy of Thymosin-α1 (Tα1) as an adjunctive immunomodulatory therapy in women with unexplained recurrent implantation failure (RIF) undergoing IVF/ICSI cycles.
Phase 2/3 • Sponsor: Fakih IVF Fertility Center • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
A new approach to tame the fear that lingers after cancer
Symptom relief Recruiting nowA sequential multiple-assignment randomized controlled trial (SMART) will be used to assess the effect of an adaptive stepped-care intervention on FCR in cancer survivors with subclinical levels of fear of cancer recurrence.
Sponsor: The University of Hong Kong • Aim: Symptom relief
Last updated Sep 02, 2026 00:00 UTC
-
Teaching the brain about pain before surgery may ease recovery
Symptom relief Recruiting nowThis randomized controlled trial investigates whether adding Pain Neuroscience Education (PNE) to standard pre-operative physiotherapy improves outcomes after lumbar laminectomy. Chronic low back pain often involves central sensitization, where the nervous system continues amplif…
Sponsor: Foundation University Islamabad • Aim: Symptom relief
Last updated Sep 05, 2026 00:00 UTC
-
New stem cell approach aims to fight tough childhood cancers
Disease control Recruiting nowHematopoietic stem cell transplantation can cure patients with blood cancer and other underlying diseases. αβ-T cell and B cell depletion has been introduced to decrease GVHD and PTLD and has demonstrated effectiveness for hematologic malignancies and non-malignant diseases addit…
Phase 1/2 • Sponsor: University of Florida • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
New drug combo aims to slow stomach cancer progression
Disease control Recruiting nowThe goal of this clinical trial is to learn if givastomig in combination with standard therapy works to treat adults with cancer in the stomach and/or esophagus (GEA adenocarcinoma). It will also help the researchers to learn more about the safety of givastomig. The main question…
Phase 2 • Sponsor: I-Mab Biopharma US Limited • Aim: Disease control
Last updated Jun 27, 2026 12:33 UTC
-
New drug combo shows promise for Hard-to-Treat lung cancer
Disease control Not yet recruitingBefotertinib is a third-generation EGFR-TKI independently developed in China. In first-line treatment of advanced non-small cell lung cancer (NSCLC) with EGFR mutations, it has demonstrated a median progression-free survival (PFS) of 22.1 months, representing the longest reported…
Phase 2 • Sponsor: Hebei Medical University Fourth Hospital • Aim: Disease control
Last updated Jun 27, 2026 09:05 UTC
-
New drug combo shows promise for Hard-to-Treat breast cancer
Disease control Not yet recruitingThis study is an open-label, prospective, phase 2, randomized controlled study to evaluate the efficacy and safety of apolitovorrelizumab (QL1706) in combination with platinum chemotherapy versus platinum chemotherapy in the treatment of advanced unresectable and or metastatic tr…
Phase 2 • Sponsor: Cancer Institute and Hospital, Chinese Academy of Medical Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Exoskeleton breakthrough: walk Hands-Free after spinal injury?
Symptom relief Recruiting nowThis study aims to demonstrate the safety and effectiveness of the personal exoskeleton in individuals with spinal cord injury (SCI).
Sponsor: Wandercraft • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Could a fizzy fiber drink soothe the gut woes of Weight-Loss drugs?
Symptom relief CompletedThe main objective of this study is to assess the impact of drinking a prebiotic soda on the gastrointestinal (GI) symptoms associated with the use of GLP-1 receptor agonists compared to usual fluid intake.
Sponsor: Olipop, PBC • Aim: Symptom relief
Last updated Aug 06, 2026 00:00 UTC
-
Immune cells engineered to hunt viruses show promise for transplant kids
Disease control Recruiting nowThe goal of this prospective clinical study is to evaluate the safety and efficacy of Multi-Virus Specific T cells (LB-DTK-MV) in pediatric patients with systemic viral infection, including CMV, EBV, and BKV, after allogeneic hematopoietic stem cell transplantation (allo-HSCT). T…
Sponsor: LucasBio • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
New weekly shot could boost weight loss for those still struggling on current meds
Disease control Recruiting nowThe main purpose of this study is to evaluate the efficacy and safety of eloralintide compared with placebo in participants with persistent obesity or overweight, with or without type 2 diabetes, and on stable incretin background therapy. Participation in the study will last abo…
Phase 3 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Sep 10, 2026 00:00 UTC